Delivery Order SPE2DB22D2206-SPE2DB25FGS03
Award Date 4/23/25
Potential Completion Date 5/14/25
Potential Value $292K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Pomalyst 4 mg capsules (21-count units) with a ceiling value of $41,555.25. This firm fixed price delivery order, with an ultimate completion date of September 10, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and fulfills this order...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pomalyst 2 mg capsules. The $22,938.76 firm-fixed-price contract has an ultimate completion date of November 22, 2024. AmerisourceBergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has an extensive history of federal contract awards supporting military and veterans' healthcare programs. This...
- This is a $114,147.61 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pomalyst 1 mg capsules, a specialty medication used for the treatment of certain types of cancer. The contract has a period of performance through January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against their indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. Valued at $12,084.50, this order is for the supply of 4562914807 POMALYST 4 MG CAPSULE 21S to support DLA medical facilities. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 18, 2023. No set-aside designation was applied to this award. As a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,348.76 from the Defense Logistics Agency (DLA) on September 9, 2025, with an ultimate completion date of September 10, 2025. The award is for 16,000 unit capsules of Pertzye DR 100s, a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency. This delivery order was competitively awarded with no set-aside designation and carries...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,418.74 to AmerisourceBergen Drug Corp on August 21, 2025, under the Pharmaceutical PV Division contract. This firm fixed-price delivery order, with an ultimate completion date of August 22, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, with a ceiling value of $6,044.60 and an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a task order under AmerisourceBergen's broader relationship with the federal government's military healthcare procurement system. The prime contractor is headquartered in...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $35,686.61 to AmerisourceBergen Drug Corp on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award to the prime contractor's Corporate Office division, located in Conshohocken, Pennsylvania. The contract falls under the Pharmaceutical Prime Vendor Global Program framework, which supports federal medical...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $17,056.07 to AmerisourceBergen Drug Corp on August 25, 2025, with completion expected by August 26, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside...
- The U.S. Defense Logistics Agency Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp (Corporate Office, Conshohocken, PA) on June 6, 2025, for pharmaceutical and medical supply products under firm fixed-price terms. The contract, valued at $1,588.45, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle extending through December 2026. This delivery order was competitively...